[EN] 1,6-NAPHTHYRIDINE COMPOUNDS AND METHODS FOR CSK MODULATION AND INDICATIONS THEREFOR [FR] COMPOSÉS DE 1,6-NAPHTYRIDINE ET PROCÉDÉS DE MODULATION DE CSK ET LEURS INDICATIONS
[EN] 1,6-NAPHTHYRIDINE COMPOUNDS AND METHODS FOR CSK MODULATION AND INDICATIONS THEREFOR [FR] COMPOSÉS DE 1,6-NAPHTYRIDINE ET PROCÉDÉS DE MODULATION DE CSK ET LEURS INDICATIONS
COMPOUNDS AND METHODS FOR CSK MODULATION AND INDICATIONS THEREFOR
申请人:Plexxikon Inc.
公开号:US20210315869A1
公开(公告)日:2021-10-14
Disclosed are compounds of Formula (I):
or a pharmaceutically acceptable salt, a tautomer, a stereoisomer, or a deuterated analog thereof, wherein R
1
, R
2
, R
3
, R
4
, and G are as described in any of the embodiments described in this disclosure; compositions thereof; and uses thereof.